Biotest AG
BTTAYOTCHealthcare
$24.23
+$0.00(+0.00%)
Market Cap$943029783
P/E Ratio—
52W High$24.27
52W Low$22.8
Biotest AG (BTTAY) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BTTAY · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.73B | $0.68B | $0.52B | $0.52B | $0.48B |
| Cost of Revenue | $0.50B | $0.40B | $0.39B | $0.43B | $0.35B |
| Gross Profit | $0.22B | $0.28B | $0.12B | $0.08B | $0.13B |
| Gross Margin %(computed) | 30.82% | 40.94% | 24.20% | 15.65% | 26.87% |
| Operating Expenses | |||||
| R&D Expenses | $0.06B | $0.07B | $0.05B | $0.05B | $0.06B |
| G&A Expenses | $0.04B | $0.03B | $0.03B | $0.03B | $0.03B |
| Total Operating Expenses | $0.13B | $0.14B | $0.13B | $0.13B | $0.13B |
| Operating Income | $0.09B | $0.14B | ($0.02B) | ($0.05B) | ($0.00B) |
| Operating Margin %(computed) | 13.01% | 20.96% | -3.22% | -9.13% | -0.27% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.03B | $0.04B | $0.02B | $0.01B | $0.01B |
| Income Before Tax | $0.05B | $0.11B | ($0.03B) | ($0.06B) | ($0.03B) |
| Income Tax Expense | $0.02B | ($0.02B) | $0.00B | $0.00B | $0.00B |
| Net Income | $0.03B | $0.13B | ($0.03B) | ($0.06B) | ($0.03B) |
| Net Margin %(computed) | 3.64% | 18.55% | -6.12% | -12.28% | -6.48% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.36 | $1.60 | $-0.40 | $-0.80 | $-0.39 |
| Wtd Avg Shares | 0.07B | 0.08B | 0.08B | 0.08B | 0.08B |
| EBITDA | $0.12B | $0.18B | $0.02B | ($0.02B) | $0.01B |
| EBITDA Margin %(computed) | 16.58% | 26.61% | 4.79% | -3.55% | 2.85% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · EUR · B
Explore more Biotest AG data
About Biotest AG (BTTAY) Income Statement
Biotest AG (BTTAY) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, BTTAY reported revenue of $0.73B, gross profit of $0.22B (gross margin 30.82%), and net income of $0.03B — a net profit margin of 3.64%.
Frequently asked questions
BTTAY · 4 questionsBiotest AG (BTTAY) reported revenue of $0.73B for 2024, up 6.1% year-over-year.
BTTAY revenueBTTAY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08